PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

New Emerson Industrial AI Platform Delivers Enterprise-Scale AI

AspenTech AVA enables customers to act faster, develop more informed strategies, improve operational reliability

The AspenTech AVA AI platform enables customers to act faster, develop more informed strategies and improve operational reliability.

Global automation leader Emerson (NYSE: EMR) today introduced the AspenTech AVA™ AI platform, specifically designed for industrial companies to accelerate AI adoption across the enterprise for measurable business impact. Offering agentic, domain-aware AI capabilities, AVA delivers the agility, efficiency and autonomy companies need to respond faster to operating conditions, continuously improve performance using trusted domain context, and act with greater confidence through AI-assisted recommendations embedded directly in operations.

While AI technologies continue to evolve rapidly, industrial organisations require practical ways to apply them safely and effectively in real operating conditions. AVA embeds decades of Emerson industrial expertise and first-principles models directly into its operational skills and workflows while leveraging large language models. In doing so, AVA enables companies to deploy the power of generative AI as a trusted operational capability and to build an enterprise operations platform that connects data, context and decision‑making across the organisation.

“AVA provides a practical way to accelerate AI adoption to deliver repeatable, scalable operational impact,” said Claudio Fayad, chief technology officer at Emerson’s Aspen Technology business. “By orchestrating AI across operations, AVA enables teams to act faster, develop more informed strategies and improve reliability – without disrupting proven processes. This is how we help customers accelerate their AI capabilities and enterprise operations platform journey.”

Designed to be data‑source agnostic and built upon existing automation infrastructure, AVA leverages the AspenTech Inmation™ Data Platform that organises and contextualises fragmented OT data across cloud, edge and on‑premise environments. The Inmation Data Platform ensures AVA has reliable, real‑time visibility into operations, while the company’s proven first‑principles models and decades of industrial expertise provide the intelligence needed to interpret conditions, evaluate options and support better decisions in real operating environments.

Beyond improving operational decision-making, AVA supports the next generation of digital-native professionals stepping into operation roles, providing consistent, expert-informed guidance. By embedding AI-assisted decision support directly into operational workflows, AVA delivers a more intuitive, responsive and autonomous user experience that aligns with how today’s workforce expects to interact with technology, while ensuring reliable execution across the enterprise at scale.

Today, AVA is available with four high‑value operational optimisation and decision‑support advisors. To help industrial companies explore how AVA’s agentic workflows can be applied within their own operating environments, Emerson offers AspenTech.ai, a web-based interactive experience where industry professionals can engage directly with AVA, examine AI‑assisted decision‑support use cases, and access Emerson’s AspenTech solution resources relevant to their operations.

Join the Emerson Exchange 365 Community

Connect with Emerson via X FacebookLinkedInYouTube

About Emerson

Emerson (NYSE: EMR) is a global automation leader delivering solutions for the most demanding technology challenges. Headquartered in St. Louis, Missouri, Emerson is engineering the autonomous future, enabling customers to optimise operations and accelerate innovation. For more information, visit Emerson.com.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026